Active Litigations

GLP-1/Ozempic

Lawsuits involving claims related to GLP-1 RA injectable drugs primarily used for managing type 2 diabetes. Products include Ozempic, Saxenda, Wegovy, and Rybelsus, which are manufactured by Novo Nordisk, and Trulicity and Mounjaro, which are manufactured by Eli Lilly and Company. Litigation stems from claims that manufacturers failed to provide adequate warnings about the risks associated with GLP-1 RAs, especially the risk for gastroparesis and other gastrointestinal injuries.

PFAS

Per- and polyfluoroalkyl substances (PFAS) are used in the manufacture of a wide variety of products due to their resistance to water, heat, and grease. These ‘forever chemicals’ persist for thousands of years, accumulate in the body and are linked to serious health conditions including kidney, liver, and testicular cancer, and ulcerative colitis. Defendants include BASF, Tyco Fire Products, 3M and Dupont, Chemours, and Corteva.
Lawsuits are categorized into three categories: water contamination (municipalities seeking settlement funding for filtration and remediation), firefighting foam (AFFF manufacturers accused of failing to warn firefighters and first responders about health risks), and drinking water personal injury/leach lawsuits (individuals alleging cancer from drinking from contaminated public water supplies).

Bard Implanted Port Catheter

The Bard PowerPort is an implanted port catheter designed to facilitate the intravenous delivery of fluids or medications. Lawsuits allege defective design, failure to warn, and negligence against Bard Access Systems (a subsidiary of Becton, Dickinson & Company). Injuries linked to the device include infections, blood clots (leading to DVT or pulmonary embolism), vascular damage, severe pain, organ puncture, and cardiac tamponade.

Depo-Provera

For over three decades, Depo-Provera has been widely used as an injectable contraceptive for women. Medroxyprogesterone acetate, the active ingredient in Depo-Provera has been linked to a significantly increased risk of developing intracranial meningiomas, a type of brain tumor. Plaintiffs who have developed brain tumors after prolonged use of the drug are pursuing legal action against the manufacturer, Pfizer, and its authorized generics for failure to adequately warn women about the risk of developing intracranial meningiomas with use of Depo-Provera exceeding one year.

NEC Infant Formula

Lawsuits have been filed against Abbott Laboratories and Mead Johnson, the manufacturers of Similac and Enfamil. These lawsuits allege that their cow milk-based infant formulas are linked to Necrotizing Enterocolitis (NEC), a severe and potentially fatal gastrointestinal disease primarily affecting premature infants. The claims assert that the manufacturers failed to adequately warn the public about the risk of NEC, which can result in serious complications such as brain injuries, cerebral palsy, and even death in premature infants exposed to their formulas.

Video Game Addiction

Video game addiction lawsuits allege that developers and publishers (Epic Games, Roblox Corporation, Activision Blizzard, Electronic Arts) intentionally create addictive games to exploit vulnerable users, especially children and teens, for profit. Plaintiffs' key claims include deceptive design driving compulsive spending, failure to warn of addiction risks, and manipulative marketing to minors. They seek compensation for physical, emotional, and financial harm, plus stricter game design and monetization regulations. The WHO clinically terms video game addiction a "gaming disorder."

Paraquat

Paraquat dichloride, or simply paraquat, is among the most widely used herbicides in the U.S. Its toxic nature has led the Environmental Protection Agency (EPA) to classify it as a "restricted use" herbicide, meaning only licensed farmers are authorized to purchase, handle, and apply it. Exposure to paraquat can occur through skin contact, inhalation, or ingestion of contaminated food or drink. A growing body of evidence suggests a link between paraquat exposure and Parkinson's disease. The main defendants in the current paraquat litigation are Syngenta and Chevron, Inc.

Roundup

Lawsuits have been filed against Bayer, Monsanto's parent company, concerning the weedkiller Roundup. The cases allege that Roundup, containing glyphosate, causes non-Hodgkin’s lymphoma and other related cancers in users. The International Agency for Research on Cancer classified glyphosate as a "probable carcinogen" in humans. Plaintiffs argue that despite this, and studies linking glyphosate to non-Hodgkin lymphoma or related cancers, Bayer and Monsanto continued to market Roundup as safe for use, failing to adequately warn consumers about potential cancer risks from exposure.

Hair Relaxer

The lawsuits claim that long-term exposure to hair relaxers, particularly by Black women, led to an increased risk of cancers including uterine cancer, ovarian cancer, and endometrial cancer. The products have been shown to contain phthalates, formaldehyde, parabens, and heavy metals which are classified as endocrine-disrupting and carcinogenic. Plaintiffs argue that the manufacturers, including L'Oréal, Dabur International, Revlon, and Namaste Laboratories, failed to adequately warn consumers about the potential health risks associated with these chemicals.

Talc

Legal claims against Johnson & Johnson primarily assert that the company’s talc-based products caused ovarian cancer. Plaintiffs allege that Johnson & Johnson knew, or should have known, that the talc it purchased to make its powder products might have been contaminated with carcinogens such as asbestos and that prolonged use of those talc-based products, especially for feminine hygiene, could lead to ovarian cancer.